| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/18/1996 | CA2201870A1 Cytoplasmic tyrosine kinase bmx protein and dna |
| 04/18/1996 | CA2201721A1 Microorganisms as therapeutic delivery systems |
| 04/18/1996 | CA2201702A1 Selective inhibition of internally initiated rna translation |
| 04/18/1996 | CA2201616A1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria |
| 04/18/1996 | CA2201592A1 Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system |
| 04/18/1996 | CA2201487A1 Attenuated viruses and method of making the same |
| 04/18/1996 | CA2201132A1 Cytokine designated lerk-6 |
| 04/18/1996 | CA2196991A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/17/1996 | EP0707077A2 Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same |
| 04/17/1996 | EP0707076A1 RNA template end-linked probe constructs and methods for use |
| 04/17/1996 | EP0707075A2 Species-specific detection of Mycobacterium kansasii |
| 04/17/1996 | EP0707071A1 Recombinant vectors derived from adenovirus for use in gene therapy |
| 04/17/1996 | EP0707070A1 Method for enhancing disease and pest resistance of plants |
| 04/17/1996 | EP0707069A2 Process for preparing virus-resistant transgenic plant |
| 04/17/1996 | EP0707068A1 Yeast vector |
| 04/17/1996 | EP0707067A2 A novel gene coding thrombin-like protease |
| 04/17/1996 | EP0707066A2 Method for producing the SspI restriction endonuclease and methylase |
| 04/17/1996 | EP0707065A2 Parietaria allergens |
| 04/17/1996 | EP0706799A2 Immunoconjugates II |
| 04/17/1996 | EP0706657A1 Inhibiting protein interactions |
| 04/17/1996 | EP0706649A1 System for real time detection of nucleic acid amplification products |
| 04/17/1996 | EP0706576A1 A method for introducing a biological substance into a target |
| 04/17/1996 | EP0706575A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 04/17/1996 | EP0706574A1 Methods for peptide synthesis and purification |
| 04/17/1996 | EP0706573A1 Protein tyrosine kinase and ligands thereof |
| 04/17/1996 | EP0706572A1 MICROBIAL TRANSFORMANTS OF $i(HANSENULA) THAT EXPRESS GLYCOLATE OXIDASE AND CATALASE |
| 04/17/1996 | EP0706571A1 Tuberculosis vaccine |
| 04/17/1996 | EP0706570A1 Plants having modified response to ethylene |
| 04/17/1996 | EP0706569A1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
| 04/17/1996 | EP0706568A1 Vertebrate apoptosis gene: compositions and methods |
| 04/17/1996 | EP0706567A1 Peptide family, designated as xenonins |
| 04/17/1996 | EP0706566A1 Conotoxins having acetylcholin receptor binding properties |
| 04/17/1996 | EP0706565A1 A synthetic gene for d4 dopamine receptors |
| 04/17/1996 | EP0706564A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 04/17/1996 | EP0706563A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 04/17/1996 | EP0706531A1 Synthesis of branched nucleic acids |
| 04/17/1996 | EP0706387A1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 04/17/1996 | EP0706319A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites |
| 04/17/1996 | EP0656951A4 Genetic sequences encoding flavonol synthase enzymes and uses therefor. |
| 04/17/1996 | EP0656940A4 Genetic sequences encoding glycosyltransferase enzymes and uses therefor. |
| 04/17/1996 | EP0651822B1 Diagnostic method |
| 04/17/1996 | EP0640136A4 Genetic sequences encoding flavonoid pathway enzymes and uses therefor. |
| 04/17/1996 | EP0630403A4 Methods for the regulation of plant fertility. |
| 04/17/1996 | EP0618815B1 Monoclonal antibodies against type i phospholipase a 2?, used as a therapeutic agent to reduce inflammation |
| 04/17/1996 | EP0598029A4 Retroviral vectors containing internal ribosome entry sites. |
| 04/17/1996 | EP0568594B1 NOVEL INSULIN ANALOGS suited for transdermal application |
| 04/17/1996 | EP0539523B1 Beta chain of the human gm-csf receptor and uses thereof |
| 04/17/1996 | EP0506826B1 Antibody antagonists of human interleukin-4 |
| 04/17/1996 | EP0483194B1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST |
| 04/17/1996 | EP0436644B1 Nucleic acid probes containing an improved molecular switch; and assays and kits incorporating same |
| 04/17/1996 | EP0424519B1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |
| 04/17/1996 | EP0414808B1 PROCESS FOR SCREENING AN EXPRESSION cDNA CLONE BANK FOR POLYNUCLEOTIDES |
| 04/17/1996 | EP0401271B1 Antigen against diabetes |
| 04/17/1996 | EP0290565B1 Vaccine containing tick antigens |
| 04/17/1996 | CN1120854A Rapamycin assay |
| 04/17/1996 | CN1120853A Method and system for enhanced production of commercially important exoproteins in gram-positive bacteria |
| 04/17/1996 | CN1120586A Sweet green pepper preventing cucumber mosaic virus and cultivated by means of gene engineering |
| 04/17/1996 | CN1120585A Live bacteria preparation containing Bacillus subtilis and its application in treatment of burns |
| 04/16/1996 | US5508468 Genetic engineering; particle bombardment |
| 04/16/1996 | US5508386 An immunoglobulin molecule containing a tetrapeptide epitope within the third complementarity-determining region in the n-terminus variable domain thereof |
| 04/16/1996 | US5508291 Treatment of feline vital disease; antitumor agents |
| 04/16/1996 | US5508264 Synergistic combinations of a cryif chimeric and cryia(c) chimeric bacillus thuringiensis delta-endotoxin; for controlling lepidopteran pests |
| 04/16/1996 | US5508263 A solid matrix having a protein coatings prepared from culturing two different nucleotide sequences; repairing bone defects |
| 04/16/1996 | US5508192 Bacterial host strains for producing proteolytically sensitive polypeptides |
| 04/16/1996 | US5508189 Regeneration of plants from cultured guard cell protoplasts |
| 04/16/1996 | US5508187 In vitro phage lambda DNA packaging system |
| 04/16/1996 | US5508186 Has vp1 minor structural protein to vp2 major structural protein ratio higher than the ratio of naturally occurring full capsid |
| 04/16/1996 | US5508184 Genetic engineering by pre-incubating in nutrient media |
| 04/16/1996 | US5508179 Incubating mixture of nad, nucleic acid oligonucleotides and a nah dinucleotide-dependent nucleic acid ligase; |
| 04/16/1996 | US5508177 Lysing, fractionating, contacting with ion exchange resins, eluting, diluting, contacting with dye-ligand resin, eluting from dye-ligand resin |
| 04/16/1996 | US5508176 Allows preparation of mutarotase in genetic engineering process in high yields |
| 04/16/1996 | US5508168 Methods and reagents for the detection of herpes simplex virus, treponema pallidum, and haemophilus ducreyi |
| 04/16/1996 | US5508167 Detecting presence or absence of an apolipoprotein e type 4 isoform(apoe4) in subject by immunoassay |
| 04/16/1996 | US5508164 Isolation of biological materials using magnetic particles |
| 04/16/1996 | US5507724 Electroporation and iontophoresis apparatus and method for insertion of drugs and genes into cells |
| 04/15/1996 | CA2160529A1 Bacillus strain and harmful organism controlling agents |
| 04/14/1996 | CA2160449A1 Galanin receptor protein, production and use thereof |
| 04/11/1996 | WO1996010647A1 Probe for diagnosing infectious diseases |
| 04/11/1996 | WO1996010645A1 Micobacterial reporter strains and uses thereof |
| 04/11/1996 | WO1996010642A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | WO1996010641A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 04/11/1996 | WO1996010640A1 Cloned dna polymerases from thermotoga neapolitana and mutants thereof |
| 04/11/1996 | WO1996010639A2 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
| 04/11/1996 | WO1996010638A1 Alpha-1-antitrypsin and antithrombine-iii variants |
| 04/11/1996 | WO1996010637A1 Human alpha4 receptor subunit of the gaba-a receptor |
| 04/11/1996 | WO1996010636A1 Novel compounds useful for preparing anti-infective agents |
| 04/11/1996 | WO1996010635A2 Genes encoding signal recognition particle of aspergillus niger |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010633A1 Chimeric influenza virus and electroporation method |
| 04/11/1996 | WO1996010632A1 Recombinant negative strand rna virus expression systems and vaccines |
| 04/11/1996 | WO1996010631A1 Nucleic acid encoding mutant matrix proteins useful for attenuation or enhancement of influenza a virus |
| 04/11/1996 | WO1996010630A1 Direct introduction of foreign materials into cells |
| 04/11/1996 | WO1996010629A1 The irs family of genes |
| 04/11/1996 | WO1996010628A1 Endothelial cell-specific enhancer |
| 04/11/1996 | WO1996010584A1 Process for extracting high-purity von willebrand factor |
| 04/11/1996 | WO1996010581A1 Process for producing anthracyclines and intermediates thereof |
| 04/11/1996 | WO1996010580A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 04/11/1996 | WO1996010577A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 04/11/1996 | WO1996010576A1 HIGH-AFFINITY OLIGONUCLEOTIDE LIGANDS TO IMMUNOGLOBULIN E (IgE) |
| 04/11/1996 | WO1996010555A1 Cationic transport reagents |